The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Theragenics sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Theragenics Corporation (Theragenics) manufactures and distributes brachytherapy, interventional, and surgical products. The company carries out partnering with physicians, healthcare providers, and medical associations to deliver life-changing treatments. Theragenics’ major products include brachytherapy seeds, medical devices, and surgical solutions. Its brands include TheraSeed, AgX100, Galt Medical, Galt Medical OEM, and Arrotek. The company’s products are used across multiple therapeutic areas, including brachytherapy, interventional radiology, interventional cardiology, and vascular surgery. The company operates in Belgium, Finland, Germany, Greece, Ireland, Netherlands, Portugal, Spain, Switzerland, the UK, Italy, the Czech Republic, Sweden, Austria, Denmark, Malta, the US, and Canada. Theragenics is headquartered in Buford, Georgia, the US. Key subsidiaries of Theragenics include Galt Medical and NeedleTech Products.
The key metrics of Theragenics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Theragenics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Theragenics.
For a detailed understanding of the performance of Theragenics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
